Investors looking for a way to capitalize on the rise of legal cannabis should look no further than Canadian cannabis giant Canopy Growth Corp., CNBC’s Jim Cramer said as stocks recovered from a multi-day selling streak. “That’s the only one you can really own and you’ve got to sell the rest. Why? Because it’s got

Shares of utility PG&E popped 37 percent in after hours trading Thursday, a sharp move upward for the stock, which has fallen more than 50 percent this week. PG&E’s stock has sunk amid concerns that its equipment could be partly responsible for the so-called Camp Fire raging in Northern California. There was no obvious cause

Federal Reserve Chairman Jerome Powell’s comments about the U.S. economy on Wednesday may have been the central bank chief’s first real acknowledgment of an economic slowdown, CNBC’s Jim Cramer says. “It’s the first time that I’ve actually heard Jay Powell say, ‘You know what? We’ve got to be careful, because there are signs of the

Warren Buffett famously used to avoid technology stocks. Now he seems to have embraced them. Berkshire Hathaway reported a 41.4 million share stake of computing giant Oracle as of the end of September, according to a regulatory filing on Wednesday. Buffett’s conglomerate also has been building a substantial stake in Apple for the last two

In an uncertain investing environment, CNBC’s Jim Cramer likes to highlight “the best of the best” of the “slowdown plays,” or stocks that do well in a weaker economy. So, on Tuesday, the “Mad Money” host profiled the turnaround at Bausch Health Companies, the drugmaker formerly known as Valeant Pharmaceuticals. Under the leadership of Chairman

The seasonal rally that many are expecting may be delayed as the market tries to find a bottom, closely followed trader Art Cashin told CNBC on Tuesday. While November historically tends to be a strong month for stocks, Cashin said the market needs to stabilize after its recent sell-off. “It had a terrible shock in